60 Degrees Pharmaceuticals (SXTP) FCF Margin (QoQ) (2023 - 2026)
60 Degrees Pharmaceuticals (SXTP) FCF Margin (QoQ) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 2.97 Mn | 1.95 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112,568.00 |
| Dec 31, 2025 | -9,994.00 |
| Sep 30, 2025 | 99,938.00 |
| Jun 30, 2025 | -50,531.00 |
| Mar 31, 2025 | -30,034.00 |
| Dec 31, 2024 | 57,486.00 |
| Sep 30, 2024 | -23,061.00 |
| Jun 30, 2024 | 5,767.00 |
| Mar 31, 2024 | -103,594.00 |
| Dec 31, 2023 | 726,143.00 |
| Sep 30, 2023 | -722,392.00 |
| Jun 30, 2023 | 234,091.00 |